BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7962138)

  • 1. Overexpression of plasminogen activator inhibitor type-1 in senescent fibroblasts from normal subjects and those with Werner syndrome.
    Goldstein S; Moerman EJ; Fujii S; Sobel BE
    J Cell Physiol; 1994 Dec; 161(3):571-9. PubMed ID: 7962138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of insulin-like growth factor binding protein-3 in conditioned medium of human fibroblasts increases with chronologic age of donor and senescence in vitro.
    Goldstein S; Moerman EJ; Baxter RC
    J Cell Physiol; 1993 Aug; 156(2):294-302. PubMed ID: 7688372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential growth state-dependent regulation of plasminogen activator inhibitor type-1 expression in senescent IMR-90 human diploid fibroblasts.
    Mu XC; Higgins PJ
    J Cell Physiol; 1995 Dec; 165(3):647-57. PubMed ID: 7593245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of c-fos expression in senescing Werner syndrome fibroblasts differs from that observed in senescing fibroblasts from normal donors.
    Oshima J; Campisi J; Tannock TC; Martin GM
    J Cell Physiol; 1995 Feb; 162(2):277-83. PubMed ID: 7822435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased transcription and modified growth state-dependent expression of the plasminogen activator inhibitor type-1 gene characterize the senescent phenotype in human diploid fibroblasts.
    Mu XC; Staiano-Coico L; Higgins PJ
    J Cell Physiol; 1998 Jan; 174(1):90-8. PubMed ID: 9397159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered regulation of fibronectin gene expression in Werner syndrome fibroblasts.
    Rasoamanantena P; Thweatt R; Labat-Robert J; Goldstein S
    Exp Cell Res; 1994 Jul; 213(1):121-7. PubMed ID: 8020582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of PAI-1 gene expression in human fibroblasts predisposed to a fibrotic phenotype.
    Higgins PJ; Slack JK; Diegelmann RF; Staiano-Coico L
    Exp Cell Res; 1999 May; 248(2):634-42. PubMed ID: 10222156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cultured pressure ulcer fibroblasts show replicative senescence with elevated production of plasmin, plasminogen activator inhibitor-1, and transforming growth factor-beta1.
    Vande Berg JS; Rose MA; Haywood-Reid PL; Rudolph R; Payne WG; Robson MC
    Wound Repair Regen; 2005; 13(1):76-83. PubMed ID: 15659039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Tisseel on expression of tissue plasminogen activator and plasminogen activator inhibitor-1.
    Diamond MP; Kruger M; Saed GM
    Fertil Steril; 2004 Jun; 81(6):1657-64. PubMed ID: 15193491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered expression and regulation of the alpha 5beta1 integrin-fibronectin receptor lead to reduced amounts of functional alpha5beta1 heterodimer on the plasma membrane of senescent human diploid fibroblasts.
    Hu Q; Moerman EJ; Goldstein S
    Exp Cell Res; 1996 May; 224(2):251-63. PubMed ID: 8612702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional regulation of tissue- and urokinase-type plasminogen activator genes by thrombin in human fetal lung fibroblasts.
    Hayakawa Y; Tazawa S; Ishikawa T; Niiya K; Sakuragawa N
    Thromb Haemost; 1995 Aug; 74(2):704-10. PubMed ID: 8585010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
    Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of donor age on the expression of a marker of replicative senescence (EPC-1) in human dermal fibroblasts.
    Tresini M; Pignolo RJ; Allen RG; Cristofalo VJ
    J Cell Physiol; 1999 Apr; 179(1):11-7. PubMed ID: 10082127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the signaling pathways involved in the proliferative life span barriers in werner syndrome fibroblasts.
    Davis T; Faragher RG; Jones CJ; Kipling D
    Ann N Y Acad Sci; 2004 Jun; 1019():274-7. PubMed ID: 15247028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrocortisone regulates the dynamics of plasminogen activator and plasminogen activator inhibitor expression in cultured murine keratinocytes.
    Bator JM; Cohen RL; Chambers DA
    Exp Cell Res; 1998 Jul; 242(1):110-9. PubMed ID: 9665808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oxidized regenerated cellulose (Interceed) on the expression of tissue plasminogen activator and plasminogen activator inhibitor-1 in human peritoneal fibroblasts and mesothelial cells.
    Gago LA; Saed G; Elhammady E; Diamond MP
    Fertil Steril; 2006 Oct; 86(4 Suppl):1223-7. PubMed ID: 17008148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
    Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
    Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal telomere erosion rates at the single cell level in Werner syndrome fibroblast cells.
    Baird DM; Davis T; Rowson J; Jones CJ; Kipling D
    Hum Mol Genet; 2004 Jul; 13(14):1515-24. PubMed ID: 15150162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant down-regulation of the plasminogen activator inhibitor 1 mRNA in pancreatic cancer.
    Warnecke-Eberz U; Prenzel KL; Baldus SE; Metzger R; Dienes HP; Bollschweiler E; Hoelscher AH; Schneider PM
    Pancreas; 2008 Mar; 36(2):173-7. PubMed ID: 18376309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular localization of urokinase-type plasminogen activator, its inhibitors, and their mRNAs in breast cancer tissues.
    Umeda T; Eguchi Y; Okino K; Kodama M; Hattori T
    J Pathol; 1997 Dec; 183(4):388-97. PubMed ID: 9496254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.